Effects of resistance exercise on treatment outcome and laboratory parameters of Takayasu arteritis with magnetic resonance imaging diagnosis: A randomized parallel controlled clinical trial
- PMID: 32761844
- PMCID: PMC7661652
- DOI: 10.1002/clc.23439
Effects of resistance exercise on treatment outcome and laboratory parameters of Takayasu arteritis with magnetic resonance imaging diagnosis: A randomized parallel controlled clinical trial
Abstract
Background: Elevated tumor necrosis factor-α (TNF-α) is correlated with refractory Takayasu arteritis (TA), and resistance exercise have been shown to inhibit TNF-α.
Hypothesis: We aimed to explore the effect of resistance exercise in the clinical management of TA.
Methods: This clinical trial enrolled a total of 342 acute TA patients, who were subsequently randomized to undergo either resistance exercise or relaxation control twice per week for 12 weeks. The disease activity was defined using the primary outcome of Birmingham Vascular Activity Score (BVAS). Secondary outcomes included levels of plasma TNF-α and C-reactive protein (CRP), and the erythrocyte sedimentation rate (ESR).
Results: BVAS scores along with other laboratory parameters obtained from the patients in the resistance exercise group showed a gradual decline throughout the course of the trial. By contrast, outcomes appeared largely unaltered in the relaxation control group patients. Analyses also revealed that plasma TNF-α displayed strong linear correlations with ESR, BVAS scores, and plasma CRP levels.
Conclusion: Resistance exercise could substantially improve treatment outcomes as well as laboratory parameters in patients with acute TA, probably through decreasing TNF-α.
Keywords: Birmingham vascular activity score; C-reactive protein; MRI; Takayasu arteritis; resistance exercise.
© 2020 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no potential conflict of interests.
Figures



Similar articles
-
Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial.Immunobiology. 2017 Feb;222(2):164-168. doi: 10.1016/j.imbio.2016.10.008. Epub 2016 Oct 14. Immunobiology. 2017. PMID: 27771172 Clinical Trial.
-
Curcumin improves treatment outcome of Takayasu arteritis patients by reducing TNF-α: a randomized placebo-controlled double-blind clinical trial.Immunol Res. 2017 Aug;65(4):969-974. doi: 10.1007/s12026-017-8917-z. Immunol Res. 2017. PMID: 28349250 Clinical Trial.
-
Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.Arthritis Res Ther. 2014 Nov 14;16(6):479. doi: 10.1186/s13075-014-0479-z. Arthritis Res Ther. 2014. PMID: 25394473 Free PMC article.
-
Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis.Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S23-8. Clin Exp Rheumatol. 2003. PMID: 14740424 Review.
-
Takayasu arteritis: diagnosis, treatment and prognosis.Int Rev Immunol. 2012 Dec;31(6):462-73. doi: 10.3109/08830185.2012.740105. Int Rev Immunol. 2012. PMID: 23215768 Review.
Cited by
-
Pathophysiology, Diagnosis, and Management of Takayasu Arteritis: A Review of Current Advances.Cureus. 2023 Jul 29;15(7):e42667. doi: 10.7759/cureus.42667. eCollection 2023 Jul. Cureus. 2023. PMID: 37525862 Free PMC article. Review.
-
Physical Exercise in Managing Takayasu Arteritis Patients Complicated With Cardiovascular Diseases.Front Cardiovasc Med. 2021 May 12;8:603354. doi: 10.3389/fcvm.2021.603354. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34055922 Free PMC article. Review.
-
The anti-inflammatory effects of exercise on autoimmune diseases: A 20-year systematic review.J Sport Health Sci. 2024 May;13(3):353-367. doi: 10.1016/j.jshs.2024.02.002. Epub 2024 Feb 9. J Sport Health Sci. 2024. PMID: 38341137 Free PMC article.
References
-
- Ishihara T, Haraguchi G, Tezuka D, Kamiishi T, Inagaki H, Isobe M. Diagnosis and assessment of Takayasu arteritis by multiple biomarkers. Circ J. 2013;77(2):477‐483. - PubMed
-
- Kallappa Parameshwarappa S, Mandjiny N, Kavumkal Rajagopalan B, Radhakrishnan N, Samavedam S, Unnikrishnan M. Intact giant abdominal aortic aneurysm due to Takayasu arteritis. Ann Vasc Surg. 2013;27(5):671‐674. - PubMed
-
- Schmidt J, Kermani TA, Bacani AK, Crowson CS, Matteson EL, Warrington KJ. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long‐term followup. Arthritis Care Res. 2012;64(7):1079‐1083. - PubMed
-
- Nasu T. Takayasu's truncoarteritis in Japan. A statistical observation of 76 autopsy cases. PatholMicrobiol. 1975;43(2‐O):140‐146. - PubMed
-
- Maksimowicz‐McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56(3):1000‐1009. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous